|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.310 EUR | +1.85% |
|
-4.89% | -6.76% |
| Jan. 14 | BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2024 | CI |
| Dec. 12 | BRAIN Biotech AG - Analyst/Investor Day |
| Capitalization | 72.32M 74.42M 68.03M 61.05M 107M 6.44B 120M 831M 308M 2.65B 279M 273M 11.63B | P/E ratio 2025 * |
-11.6x | P/E ratio 2026 * | -30.7x |
|---|---|---|---|---|---|
| Enterprise value | 75.02M 77.21M 70.58M 63.33M 111M 6.69B 124M 862M 319M 2.75B 290M 284M 12.07B | EV / Sales 2025 * |
1.24x | EV / Sales 2026 * | 1.15x |
| Free-Float |
39.38% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: BRAIN Biotech AG
More press releases
| 1 day | +1.85% | ||
| 1 week | -4.89% | ||
| Current month | -6.76% | ||
| 1 month | -15.35% | ||
| 3 months | +27.31% | ||
| 6 months | +42.06% | ||
| Current year | -6.76% |
1 week
3.05
3.65
1 month
3.053.65
Current year
3.053.65
1 year
1.424.40
3 years
1.429.90
5 years
1.4211.00
10 years
1.4227.75
| Director | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 55 | 2022-09-30 | |
Alexander Pelzer
CTO | Chief Tech/Sci/R&D Officer | 39 | 2022-12-31 |
Martina Schuster
IRC | Investor Relations Contact | - | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 2017-03-08 | |
Michael Majerus
CHM | Chairman | 63 | 2023-03-07 |
Stephen Catling
BRD | Director/Board Member | 60 | 2020-10-13 |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +1.85% | -4.89% | -15.56% | -66.90% | 74.42M | ||
| +0.44% | +0.44% | -49.15% | -62.90% | 161M | ||
| Average | +1.14% | -2.22% | -32.35% | -64.90% | 117.79M | |
| Weighted average by Cap. | +0.89% | -1.24% | -38.54% | -64.16% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 60.73M 62.5M 57.13M 51.26M 90.03M 5.41B 101M 698M 258M 2.22B 234M 230M 9.77B | 65.56M 67.47M 61.68M 55.35M 97.2M 5.84B 109M 753M 279M 2.4B 253M 248M 10.55B |
| Net income | -6.15M -6.33M -5.79M -5.19M -9.12M -548M -10.19M -70.68M -26.18M -225M -23.74M -23.26M -990M | -2.3M -2.37M -2.16M -1.94M -3.41M -205M -3.81M -26.4M -9.78M -84.1M -8.87M -8.69M -370M |
| Net Debt | 2.71M 2.79M 2.55M 2.29M 4.01M 241M 4.48M 31.11M 11.52M 99.08M 10.45M 10.24M 436M | 2.79M 2.87M 2.62M 2.35M 4.14M 249M 4.62M 32.04M 11.87M 102M 10.76M 10.54M 449M |
More financial data
* Estimated data
Employees
318
Calendar
2025-02-26
- Q1 2025 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-01-17 | 3.310 € | +1.85% | 5,871 |
| 25-01-16 | 3.250 € | -1.22% | 44,805 |
| 25-01-15 | 3.290 € | -7.84% | 36,581 |
| 25-01-14 | 3.570 € | +0.85% | 11,307 |
| 25-01-13 | 3.540 € | +1.72% | 13,128 |
Delayed Quote Xetra, January 17, 2025 at 11:36 am EST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.310EUR
Average target price
6.638EUR
Spread / Average Target
+100.53%
Annual profits - Rate of surprise
- Stock Market
- Equities
- BNN Stock